Gilead and US Government Settle HIV Drug Patent Dispute, Dismissing All Claims

Gilead Sciences and the federal government have agreed to terminate all claims and counterclaims involved in a protracted intellectual property and contract dispute regarding the HIV prevention medications Truvada and Descovy. This legal resolution was documented in stipulations of voluntary dismissal filed this week in both the Federal Circuit and Delaware federal court. The conclusion comes as both parties were navigating an appeal process. For further details on the developments of this case, the original article at Law360 provides additional context.